• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Aartipharm Share Price

    Aarti Pharmalabs Share PriceAarti Pharmalabs

    Small Cap 2.8k Result
    ₹461.95
    11.65 (2.59%)
    As on 30 September, 2023 | 06:11 BSE: 543748 NSE: AARTIPHARMISIN: INE0LRU01027

    Aarti Pharmalabs Performance

    Day Range

    • Low 454.55
    • High 466.2
    461.95

    52 Week Range

    • Low 234.8
    • High 476.05
    461.95
    • Open Price454.6
    • Previous Close450.3
    • Volume129514

    Start SIP in Aarti Pharmalabs

    Start SIP

    Aarti Pharmalabs Share Price

    • Over 1 Month 13.96%
    • Over 3 Month 22.74%
    • Over 6 Month 65.54%

    Aarti Pharmalabs Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 4,187
    Price to Book Ratio 2.7
    EPS 19
    Dividend 0
    Relative Strength Index 65.8
    Money Flow Index 49.55
    MACD Signal 17.86
    Average True Range 16.81

    Aarti Pharmalabs Investment Rating

    • Master Rating:

    • Aarti Pharmalabs has an operating revenue of Rs. 2,863.89 Cr. on a trailing 12-month basis. An annual revenue growth of 62% is outstanding, Pre-tax margin of 13% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 18% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 11% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 35 which is a POOR score indicating inconsistency in earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Aarti Pharmalabs Financials
    IndicatorJun 2023Mar 2023Dec 2022Mar 2022
    Oper Rev Qtr Cr 3583741,137365
    Operating Expenses Qtr Cr 281297905296
    Operating Profit Qtr Cr 777723268
    Depreciation Qtr Cr 15144212
    Interest Qtr Cr 46154
    Tax Qtr Cr 1517459
    Net Profit Qtr Cr 484013245
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,513944
    Operating Expenses Annual Cr 1,203761
    Operating Profit Annual in Cr 308180
    Depreciation Cr 5637
    Interest Annual Cr 2011
    Tax Annual Cr 6227
    Net Profit Annual Cr 172107
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 229-65
    Cash from Investing Activity Annual Cr -116-134
    Cash from Financing Annual Activity Cr -157255
    Net Cash Flow Annual Cr -4356
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,4391,284
    Fixed Assets Annual Cr 950888
    Total Non Current Assets Annual Cr 1,004937
    Total Current Assets Annual Cr 959890
    Total Assets Annual Cr 1,9631,827
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 159282
    ROE Annual % 128
    ROCE Annual % 1711
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2019
    IndicatorJun 2023Mar 2023Dec 2022Mar 2022
    Oper Rev Qtr Cr 4584851,460460
    Operating Expenses Qtr Cr 3734051,198385
    Operating Profit Qtr Cr 858026276
    Depreciation Qtr Cr 17164714
    Interest Qtr Cr 46155
    Tax Qtr Cr 17165111
    Net Profit Qtr Cr 474315149
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,9481,202
    Operating Expenses Annual Cr 1,603993
    Operating Profit Annual in Cr 342207
    Depreciation Cr 6342
    Interest Annual Cr 2112
    Tax Annual Cr 6733
    Net Profit Annual Cr 193122
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 263-44
    Cash from Investing Activity Annual Cr -158-139
    Cash from Financing Annual Activity Cr -163260
    Net Cash Flow Annual Cr -5878
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,5581,386
    Fixed Assets Annual Cr 1,026968
    Total Non Current Assets Annual Cr 1,0751,012
    Total Current Assets Annual Cr 1,1561,028
    Total Assets Annual Cr 2,2312,040
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 172304
    ROE Annual % 129
    ROCE Annual % 1711
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1817

    Aarti Pharmalabs Technicals

    EMA & SMA

    Current Price
    ₹461.95
    11.65 (2.59%)
    • Bullish Moving Average
    • ___
    • 14
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹435.17
    • 50 Day
    • ₹407.02
    • 100 Day
    • ₹380.01
    • 200 Day
    • ₹
    • 20 Day
    • ₹439.74
    • 50 Day
    • ₹391.13
    • 100 Day
    • ₹380.22
    • 200 Day
    • ₹

    Aarti Pharmalabs Resistance and Support

    PIVOT
    ₹460.9
    Resistance
    First Resistance ₹467.25
    Second Resistance ₹472.55
    Third Resistance ₹478.9
    RSI 65.8
    MFI 49.55
    MACD Single Line 17.86
    MACD 16.34
    Support
    First Resistance ₹455.6
    Second Resistance ₹449.25
    Third Resistance ₹443.95

    Aarti Pharmalabs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 139,538 8,405,769 60.24
    Week 124,585 6,788,615 54.49
    1 Month 341,180 18,297,468 53.63
    6 Month 305,205 17,155,579 56.21

    Aarti Pharmalabs Result Highlights

    Aarti Pharmalabs Synopsis

    NSE-Medical-Ethical Drugs

    Aarti Pharmalabs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1511.25 Cr. and Equity Capital is Rs. 45.31 Cr. for the Year ended 31/03/2023. Aarti Pharmalabs Ltd. is a Public Limited Listed company incorporated on 22/11/2019 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2019PLC110964 and registration number is 110964.
    Market Cap 4,186
    Sales 1,869
    Shares in Float 4.89
    No of funds 136
    Yield
    Book Value 2.91
    U/D Vol ratio 2.3
    LTDebt / Equity
    Alpha 0.18
    Beta 0.4

    Aarti Pharmalabs

    Owner NameJun-23Mar-23Jan-23
    Promoters 45.98%45.98%44.16%
    Mutual Funds 2.72%5.11%6.7%
    Insurance Companies 7.06%7.73%8.01%
    Foreign Portfolio Investors 7.43%7.69%11.89%
    Financial Institutions/ Banks 0.02%0.02%0.02%
    Individual Investors 30.23%28.35%24.66%
    Others 6.56%5.12%4.56%

    Aarti Pharmalabs Management

    Name Designation
    Mr. Chandrakant Vallabhaji Gogri Chairman Emeritus
    Mr. Rashesh C Gogri Chairman & Non-Exe.Director
    Mrs. Hetal Gogri Gala Vice Chairperson & M.D
    Mr. Narendra J Salvi Managing Director
    Mr. Rajendra V Gogri Non Executive Director
    Mr. Parimal H Desai Non Executive Director
    Mr. Bhavesh R Vora Independent Director
    Mrs. Jeenal K Savla Independent Director
    Mrs. Rupal A Vora Independent Director
    Mr. Vilas Gajanan Gaikar Independent Director
    Mr. Vinay G Nayak Independent Director

    Aarti Pharmalabs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Aarti Pharmalabs Corporate Action

    Date Purpose Remarks
    2023-08-05 Quarterly Results
    2023-05-12 Audited Results

    Aarti Pharmalabs MF Shareholding

    Name Amount(cr)
    Aditya Birla Sun Life Flexi Cap Fund Growth 17296
    Axis Small Cap Fund Regular Growth 15847
    HDFC Large and Mid Cap Fund Growth 11198
    UTI Mid Cap Fund Regular Plan Growth 8881
    HDFC Multi Cap Fund Regular Growth 8263
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Aarti Pharmalabs FAQs

    What is Share Price of Aarti Pharmalabs ?

    Aarti Pharmalabs share price is ₹461 As on 30 September, 2023 | 05:58

    What is the Market Cap of Aarti Pharmalabs ?

    The Market Cap of Aarti Pharmalabs is ₹4186.5 Cr As on 30 September, 2023 | 05:58

    What is the P/E ratio of Aarti Pharmalabs ?

    The P/E ratio of Aarti Pharmalabs is As on 30 September, 2023 | 05:58

    What is the PB ratio of Aarti Pharmalabs ?

    The PB ratio of Aarti Pharmalabs is 2.7 As on 30 September, 2023 | 05:58

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.